Get 25% discount on our yearly plans! Subscribe now
Market Cap | |
Total Shares Outstanding | |
Book Value | |
PE Ratio |
PS Ratio | |
PB Ratio | |
Forward PE Ratio | |
ROIC |
Return on Aseets | |
Return on Equity | |
Dividend | |
Dividend Yield |
Total Assets | 251.04M |
Total Liability | 15.45M |
Assets-to-Libability Ratio | 16.25 |
Total Current Assets | 669.79K |
Total Current Liability | 7.75M |
Current Ratio | 0.09 |
Quick Ratio | - |
Debt to Equity Ratio | - |
Net Income | |
EPS | |
EBITA |
Gross Profit | |
Gross Profit Margin | |
Operating Margin |
Net Profit Margin |
5 Days MA | |
10 Days MA | |
20 Days MA | |
50 Days MA | |
200 Days MA |
52 Weeks High | |
52 Weeks low | |
All Time High |
RSI | |
MACD |
Shares Float | |
Shares Short |
% Short | |
% Insider |
% Institutions |
Social Capital Suvretta Holdings Corp I (DNAA)
As of August 19, 2022, Social Capital Suvretta Holdings Corp. I was acquired by Akili Interactive Labs, Inc., in a reverse merger transaction. Social Capital Suvretta Holdings Corp. I does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology industry. The company was incorporated in 2021 and is based in Henderson, Nevada.
Exchange: NASDAQ
IPO Date: 6/30/2021
Sector: Healthcare
Industry: Health Care Technology
Employees: 0
Address: 2850 West Horizon Ridge Parkway, Henderson, NV, United States, 89052
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | Totals | |
---|---|---|---|---|---|---|---|---|---|
Assets | 251.04K | 250.77K | 251.19K | 251.42K | 631.328 | 25.117 | 25 | 1.01M | |
Current Assets | 669.794 | 612.774 | 932.223 | 1.42K | 243.138 | - | - | 3.87K | |
Cash And Short Term Investments | 5.13K | 69.991 | 428.189 | 519.568 | 223.538 | - | - | 6.37K | |
Net Receivables | 17 | - | - | - | - | - | - | 17 | |
Inventory | - | - | - | - | - | - | - | - | |
Other Current Assets | -4.48K | 542.783 | 504.034 | 897.311 | 19.6 | - | - | -2.52K | |
Non Current Assets | 250.37K | 250.16K | 250.26K | 250.00K | 388.19 | 25.117 | 25 | 1.00M | |
Property Plant Equipment | - | - | - | - | - | - | - | - | |
Long Term Investments | - | - | - | - | - | - | - | - | |
Non Currrent Assets Other | -3.74K | 250.16K | 250.26K | 250.00K | 388.19 | - | - | 747.06K | |
Liabilities | 15.45K | 13.45K | 9.69K | 7.75K | 611.653 | 5.299 | 5.138 | 46.96K | |
Current Liabilities | 7.75K | 5.75K | 1.99K | 48.741 | 611.653 | 5.299 | 5.138 | 16.16K | |
Accounts Payable | 17.465 | 53.147 | 5 | 10.314 | 300.088 | - | - | 386.014 | |
Short Long Term Debt | 250 | - | - | - | 300 | 0.255 | 0.138 | 550.393 | |
Other Current Liabilities | 7.38K | 5.69K | 1.98K | 48.741 | 311.653 | 5 | - | 15.42K | |
Non Current Liabilities | 7.70K | 7.70K | 7.70K | 7.70K | - | - | - | 30.80K | |
Long Term Debt | - | - | - | - | - | - | - | - | |
Other Liabilities | 258.07K | 257.70K | 257.71K | 257.70K | - | - | - | 1.03M | |
Stockholder Equity | 235.59K | 237.32K | 241.50K | 243.67K | 19.675 | 19.818 | 19.862 | 958.14K | |
Preferred Stock Equity | - | - | - | - | - | - | - | - | |
Liabilities And Stockholders Equity | 251.04K | 250.77K | 251.19K | 251.42K | 631.328 | - | - | 1.01M | |
Common Equity | 0.689 | 0.689 | 0.689 | 0.689 | 0.633 | - | - | 3.389 | |
Retained Earnings | -14.78K | -12.68K | -8.51K | -6.33K | -5.325 | - | - | -42.31K | |
Totals | 1.27M | 1.52M | 1.52M | 1.52M | 4.68K | 85.905 | 80.276 | 5.82M |
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | 12/31/2021 | Totals | |
---|---|---|---|
Assets | 251.19K | 251.19K | |
Current Assets | 932.223 | 932.223 | |
Cash And Short Term Investments | 428.189 | 428.189 | |
Other Current Assets | 504.034 | 504.034 | |
Non Current Assets | 250.26K | 250.26K | |
Non Currrent Assets Other | 250.26K | 250.26K | |
Liabilities | 9.69K | 9.69K | |
Current Liabilities | 1.99K | 1.99K | |
Accounts Payable | 5 | 5 | |
Other Current Liabilities | 1.98K | 1.98K | |
Non Current Liabilities | 7.70K | 7.70K | |
Other Liabilities | 257.71K | 257.71K | |
Stockholder Equity | 241.50K | 241.50K | |
Liabilities And Stockholders Equity | 251.19K | 251.19K | |
Common Equity | 0.689 | 0.689 | |
Retained Earnings | -8.51K | -8.51K | |
Totals | 1.52M | 1.52M |
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | Totals | |
---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | |
Cost Of Revenue | - | - | - | - | - | - | - | |
Gross Profit | - | - | - | - | - | - | - | |
Operating Expenses | 2.07K | 4.20K | - | 263.347 | 0.143 | - | 6.54K | |
Selling General Administrative | - | - | - | 263.347 | 0.143 | - | 263.48999999999995 | |
Research Development | - | - | - | - | - | - | - | |
Other Operating Expenses | 2.07K | 4.20K | - | 263.347 | 0.143 | - | 6.54K | |
Operating Income | -2.07K | -4.20K | - | -263.347 | -0.143 | - | -6.54K | |
Net Interest Income | 337.595 | 25.176 | - | 3.042 | - | - | 365.813 | |
Interest Income | 337.595 | 25.176 | - | 3.042 | - | - | 365.813 | |
Interest Expense | 337.595 | 25.176 | - | 3.042 | - | - | 365.813 | |
Other Income Expense Net | 337.595 | 25.176 | - | 3.042 | - | - | 365.813 | |
Income Before Tax | -1.73K | -4.18K | - | -260.305 | -0.143 | - | -6.17K | |
Tax Provision | - | - | - | - | - | - | - | |
NetIncome | -1.73K | -4.18K | - | -260.305 | -0.143 | - | -6.17K | |
NetIncome Applicable To Common Shares | -3.47K | -8.35K | -2.66K | -520.61 | -0.143 | -5.182 | -15.01K | |
Ebit | -2.07K | -4.20K | -2.67K | -263.347 | -0.143 | - | -9.20K | |
Basic EPS | - | -0.13 | -0.07 | -0.01 | -0.01 | - | -0.22000000000000003 | |
Totals | -5.59K | -16.60K | -5.33K | -765.7149999999999 | -0.29600000000000004 | -5.182 | -28.29K |
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | 12/31/2021 | Totals | |
---|---|---|---|
Revenue | - | - | |
Cost Of Revenue | - | - | |
Gross Profit | - | - | |
Operating Expenses | - | - | |
Selling General Administrative | - | - | |
Research Development | - | - | |
Other Operating Expenses | - | - | |
Operating Income | - | - | |
Net Interest Income | - | - | |
Interest Income | - | - | |
Interest Expense | - | - | |
Other Income Expense Net | - | - | |
Income Before Tax | - | - | |
Tax Provision | - | - | |
NetIncome | - | - | |
NetIncome Applicable To Common Shares | -2.93K | -2.93K | |
Ebit | -2.94K | -2.94K | |
Basic EPS | -0.08 | -0.08 | |
Totals | -5.86K | -5.86K |
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | Totals | |
---|---|---|---|---|---|---|---|---|
Cash From Operating Activities | -174.947 | -358.198 | -305.676 | -1.15K | -19.699 | -0.138 | -2.01K | |
Net Income | -1.73K | -4.18K | -2.66K | -260.305 | -0.143 | -5.182 | -8.84K | |
Depreciation | - | - | - | - | - | - | - | |
Extraordinary Items | - | - | - | - | - | - | - | |
Change Receivables | - | - | - | - | - | - | - | |
Change To Inventory | - | - | - | - | - | - | - | |
Change To Liabilities | 1.72K | 3.76K | 2.38K | - | - | - | 7.85K | |
Change To Net Income | -337.595 | -25.176 | -5.947 | -3.042 | -3.042 | 5 | -369.80199999999996 | |
ChangeToOperatingActivities | 178.224 | 118.687 | -14.844 | -867.485 | -19.556 | 0.044 | -604.9300000000001 | |
Cash flows From Investing Activities | - | - | -50.00K | -250.00K | -250.00K | -250.00K | -800.00K | |
Capital Expenditures | - | - | - | - | - | - | - | |
Other Cashflows From Investing Activities | - | - | -50.00K | -250.00K | -250.00K | -250.00K | -800.00K | |
Cash From Financing Activities | 250 | 250 | 50.30K | 251.67K | 243.237 | 0.138 | 302.71K | |
Net Borrowings | 250 | 250 | -26.427 | -287.265 | 325.437 | 0.255 | 512 | |
Sale Purchase Of Stock | - | - | - | - | - | - | - | |
Dividends Paid | - | - | - | - | - | - | - | |
Other Cashflows From Financing Activities | 250 | - | -73.638 | 251.67K | -82.2 | -0.117 | 251.76K | |
Cash And Cash Equivalents Changes | 75.053 | -358.198 | - | - | - | - | -283.145 | |
Totals | 475.1589999999998 | -540.908 | -50.41K | 771.7079999999842 | -499.56K | -500.00K | -1.05M |
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | 12/31/2021 | Totals | |
---|---|---|---|
Cash From Operating Activities | -1.46K | -1.46K | |
Net Income | -2.93K | -2.93K | |
Depreciation | - | - | |
Extraordinary Items | - | - | |
Change Receivables | - | - | |
Change To Inventory | - | - | |
Change To Liabilities | 2.38K | 2.38K | |
Change To Net Income | -3.989 | -3.989 | |
ChangeToOperatingActivities | -901.841 | -901.841 | |
Cash flows From Investing Activities | -300.00K | -300.00K | |
Capital Expenditures | - | - | |
Other Cashflows From Investing Activities | -300.00K | -300.00K | |
Cash From Financing Activities | 301.97K | 301.97K | |
Net Borrowings | 12 | 12 | |
Sale Purchase Of Stock | - | - | |
Dividends Paid | - | - | |
Other Cashflows From Financing Activities | -441.828 | -441.828 | |
Cash And Cash Equivalents Changes | - | - | |
Totals | -301.37K | -301.37K |